Compare AstraZeneca plc (AZN) vs Direxion Daily Semiconductor Bear 3X Shares (SOXS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AstraZeneca plc vs Direxion Daily Semiconductor Bear 3X Shares — how do they compare? AstraZeneca plc trades at $158.4 (market cap $248.14B), while Direxion Daily Semiconductor Bear 3X Shares trades at $40.77. The key difference: AstraZeneca plc pays a 2.01% dividend while Direxion Daily Semiconductor Bear 3X Shares pays none. Which is the better fit depends on your goals.
| AZN | SOXS | |
|---|---|---|
Market Cap | $248.14B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $209.48 | $1.49K |
52-Week Low | $147.06 | $32.50 |
Enterprise Value | $275.41B | — |
Dividend Yield | 2.01% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AstraZeneca (AZN) trades at $158.48, down 2.12% amid bearish technical signals and merger speculation. The stock shows strong fundamentals with revenue growth from $54.1B in 2024 to $58.7B in 2025 and net income reaching $10.2B. Recent earnings beats and a 47.5% analyst buy rating contrast with technical indicators showing oversold conditions near key support at $155.
Investment outlook remains positive based on earnings momentum and valuation metrics (P/E 23.76), though risks include potential merger integration challenges and ongoing legal investigations. The company's robust cash flow generation and dividend payments provide shareholder value support despite near-term volatility.
SOXS, the Direxion Daily Semiconductor Bear 3X ETF, is trading at $40.97, down 9.38% today amid volatile semiconductor sector conditions. The technical picture remains bearish with moving averages signaling continued downward pressure, though oversold RSI levels suggest potential for near-term bounce. Recent news highlights SOXS benefiting from AI-fueled tech rally concerns and semiconductor stock sell-offs, with the fund executing a 1:10 stock split effective July 26, 2026.
As a leveraged inverse ETF, SOXS offers amplified exposure to semiconductor sector declines but carries significant decay and volatility risks. The fund's performance is heavily dependent on continued semiconductor weakness, which faces fundamental challenges from AI infrastructure growth and memory chip competition. Investors should understand the complex nature of inverse leveraged products before considering positions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AstraZeneca plc
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →About Direxion Daily Semiconductor Bear 3X Shares
SOXS is a leveraged ETF that seeks daily investment results corresponding to 300% of the inverse (opposite) of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bearish (short) position on the semiconductor sector. Due to the effects of compounding and leverage, SOXS is intended to be held for a single day and is not suitable for long-term investment.
Read more on SOXS →
